Status:
UNKNOWN
Metoclopramide Versus Hyoscine Butylbromide in Shortening Duration of First Stage of Labour
Lead Sponsor:
Uwakwe Emmanuel Chijioke
Conditions:
Duration of Labour
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
BACKGROUND Prolonged labour can lead to increased maternal and neonatal mortality and morbidity. The risk for complications of prolonged labour is more in poor resource settings. Active management of ...
Detailed Description
BACKGROUND Prolonged labour can lead to increased maternal and neonatal mortality and morbidity. The risk for complications of prolonged labour is more in poor resource settings. Active management of ...
Eligibility Criteria
Inclusion
- 1\. All nullipara who gave consent
Exclusion
- 1\. those who refused consent
Key Trial Info
Start Date :
January 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05222646
Start Date
January 3 2022
End Date
August 30 2022
Last Update
February 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AEFUTHA
Abakaliki, Ebonyi State, Nigeria, 234